VDAC1 and cancer: In malignant tumors, otherwise, overexpression of VDAC1 was observed, notably in those with a more severe clinical course, which, according to some authors, could be associated with adaptive changes in the energy metabolism of cancer cells, with increased aerobic glycolysis (Warburg effect) that results in greater resistance to cell death (19, 22, 27, 59–63).